These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 26389682)

  • 1. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
    Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
    Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the advancements in the treatment of agitation in Alzheimer's disease.
    Porsteinsson AP; Antonsdottir IM
    Expert Opin Pharmacother; 2017 Apr; 18(6):611-620. PubMed ID: 28300462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in the treatment of agitation in Alzheimer's disease.
    Antonsdottir IM; Smith J; Keltz M; Porsteinsson AP
    Expert Opin Pharmacother; 2015; 16(11):1649-56. PubMed ID: 26159445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
    Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
    Expert Opin Pharmacother; 2023 Apr; 24(6):691-703. PubMed ID: 36958727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease.
    Herrmann N; Wang HJ; Song BX; Bawa KK; Lanctôt KL
    Expert Opin Drug Saf; 2022 Oct; 21(10):1289-1301. PubMed ID: 36252087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
    Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
    Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.
    Garay RP; Grossberg GT
    Expert Opin Investig Drugs; 2017 Jan; 26(1):121-132. PubMed ID: 27936965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease.
    Wang HJ; Chinna-Meyyappan A; Feldman OJ; Lanctôt KL
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):289-303. PubMed ID: 38822731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can antidepressant medication relieve agitation in Alzheimer's disease?
    Porsteinsson AP; Smith JS; Keltz MA; Antonsdottir IM
    Expert Rev Neurother; 2014 Sep; 14(9):969-71. PubMed ID: 25148535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational drugs for treating agitation in persons with dementia.
    Garay RP; Citrome L; Grossberg GT; Cavero I; Llorca PM
    Expert Opin Investig Drugs; 2016 Aug; 25(8):973-83. PubMed ID: 27232589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.
    Liu CS; Chau SA; Ruthirakuhan M; Lanctôt KL; Herrmann N
    CNS Drugs; 2015 Aug; 29(8):615-23. PubMed ID: 26271310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease.
    Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
    J Am Med Dir Assoc; 2024 Oct; 25(10):105173. PubMed ID: 39053890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
    Aga VM
    Am J Geriatr Psychiatry; 2019 Oct; 27(10):1099-1107. PubMed ID: 31288974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of citalopram in the treatment of agitation in Alzheimer's disease.
    Porsteinsson AP; Keltz MA; Smith JS
    Neurodegener Dis Manag; 2014; 4(5):345-9. PubMed ID: 25405648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.
    Kongpakwattana K; Sawangjit R; Tawankanjanachot I; Bell JS; Hilmer SN; Chaiyakunapruk N
    Br J Clin Pharmacol; 2018 Jul; 84(7):1445-1456. PubMed ID: 29637593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.